Erratum: The global burden of cancer 2013 (JAMA Oncology (2015) DOI: 10.1001/jamaoncol.2015.0735);The Global Burden of Cancer 2013

JAMA Oncology

Volumn 1, Issue 4, 2015, Pages 505-527

  Fitzmaurice, Christina ^a   Dicker, Daniel ^a   Pain, Amanda ^a   Hamavid, Hannah ^a   Moradi Lakeh, Maziar ^a,b   MacIntyre, Michael F ^a   Allen, Christine ^a   Hansen, Gillian ^a   Woodbrook, Rachel ^a   Wolfe, Charles ^c   Hamadeh, Randah R ^d   Moore, Ami ^e   Werdecker, Andrea ^f   Gessner, Bradford D ^g   Te Ao, Braden ^h   McMahon, Brian ⁱ   Karimkhani, Chante ^j   Yu, Chuanhua ^k   Cooke, Graham S ^l   Schwebel, David C ^m   Carpenter, David O ⁿ   Pereira, David M ^o   Nash, Denis ^p   Kazi, Dhruv S ^q   De Leo, Diego ^r   Plass, Dietrich ^s   Ukwaja, Kingsley N ^t   Thurston, George D ^u   Yun Jin, Kim ^v   Simard, Edgar P ^w   Mills, Edward ^x   Park, Eun Kee ^y   Catalá López, Ferrán ^z   DeVeber, Gabrielle ^aa   Gotay, Carolyn ^ab   Khan, Gulfaraz ^ac   Hosgood, H Dean ^ad   Santos, Itamar S ^ae   Leasher, Janet L ^af   Singh, Jasvinder ^ag   Leigh, James ^ah   Jonas, Jost B ^ai   Sanabria, Juan ^aj,ak   Beardsley, Justin ^al   Jacobsen, Kathryn H ^am   Takahashi, Ken ^an   Franklin, Richard C ^ao   Ronfani, Luca ^ap   Montico, Marcella ^ap   Naldi, Luigi ^aq   Tonelli, Marcello ^ar   Geleijnse, Johanna ^as   Petzold, Max ^at,au   Shrime, Mark G ^av   Younis, Mustafa ^aw   Yonemoto, Naohiro ^ax   Breitborde, Nicholas ^ay   Yip, Paul ^az   Pourmalek, Farshad ^ab   Lotufo, Paulo A ^ae   Esteghamati, Alireza ^ba   Hankey, Graeme J ^bb   Ali, Raghib ^bc   Lunevicius, Raimundas ^bd   Malekzadeh, Reza ^be   Dellavalle, Robert ^bf,bg   Weintraub, Robert ^bh,bi   Lucas, Robyn ^bj   Hay, Roderick ^bk   Rojas Rueda, David ^bl   Westerman, Ronny ^bm   Sepanlou, Sadaf G ^be   Nolte, Sandra ^bn   Patten, Scott ^ar   Weichenthal, Scott ^bo   Abera, Semaw Ferede ^bp   Fereshtehnejad, Seyed Mohammad ^bq   Shiue, Ivy ^br,bs   Driscoll, Tim ^bt   Vasankari, Tommi ^bu   Alsharif, Ubai ^bn   Rahimi Movaghar, Vafa ^bv   Vlassov, Vasiliy V ^bw   Marcenes, W S ^bx   Mekonnen, Wubegzier ^by   Melaku, Yohannes Adama ^bp   Yano, Yuichiro ^bz   Artaman, Al ^ca   Campos, Ismael ^av   MacLachlan, Jennifer ^cb   Mueller, Ulrich ^bm   Kim, Daniel ^cc   Trillini, Matias ^cd   Eshrati, Babak ^ce   Williams, Hywel C ^cf   Shibuya, Kenji ^cg   Dandona, Rakhi ^ch   Murthy, Kinnari ^ch   Cowie, Benjamin ^cb   Amare, Azmeraw T ^ci   Antonio, Carl Abelardo ^cj   Castañeda Orjuela, Carlos ^ck   Van Gool, Coen H ^cl   Violante, Francesco ^cm   Oh, In Hwan ^cn   Deribe, Kedede ^by,co   Soreide, Kjetil ^cp,cq   Knibbs, Luke ^cr   Kereselidze, Maia ^cs   Green, Mark ^ct   Cardenas, Rosario ^cu   Roy, Nobhojit ^bq   Tillmann, Taavi ^cv   Li, Yongmei ^cw   Krueger, Hans ^ab   Monasta, Lorenzo ^ap   Dey, Subhojit ^cx   Sheikhbahaei, Sara ^ba   Hafezi Nejad, Nima ^ba   Kumar, G Anil ^ch   Sreeramareddy, Chandrashekhar T ^cy   Dandona, Lalit ^a,ch   Wang, Haidong ^a   Vollset, Stein Emil ^cq,cz   Mokdad, Ali ^a   Salomon, Joshua A ^av   Lozano, Rafael ^a,da   Vos, Theo ^a   Forouzanfar, Mohammad ^a   Lopez, Alan ^bh   Murray, Christopher ^a   Naghavi, Mohsen ^a   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ARABIAN GULF UNIVERSITY   (Bahrain)

^e UNIVERSITY OF NORTH TEXAS   (United States)

^f Institute of Medical Sociology and Social Medicine   (Germany)

^g Agence de Medecine Preventive   (France)

^h AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

ⁱ ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^j Columbia University ^*  (United States)

^k WUHAN UNIVERSITY   (China)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ STATE UNIVERSITY OF NEW YORK   (United States)

^o UNIVERSITY OF PORTO   (Portugal)

^p CITY UNIVERSITY OF NEW YORK   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r GRIFFITH UNIVERSITY   (Australia)

^s UMWELTBUNDESAMT   (Germany)

^t FEDERAL TEACHING HOSPITAL   (Nigeria)

^u NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v Southern University College   (Malaysia)

^w EMORY UNIVERSITY   (United States)

^x UNIVERSITY OF OTTAWA   (Canada)

^y Kosin University   (South Korea)

^z Ministry of Environment   (Spain)

^aa UNIVERSITY OF TORONTO   (Canada)

^ab UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^ac UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^ad ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^ae UNIVERSITY OF SÃO PAULO   (Brazil)

^af NOVA SOUTHEASTERN UNIVERSITY   (United States)

^ag The University of Alabama at Birmingham   (United States)

^ah UNIVERSITY OF SYDNEY   (Australia)

^ai UNIVERSITY OF HEIDELBERG   (Germany)

^aj CASE WESTERN RESERVE UNIVERSITY   (United States)

^ak ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^al UNIVERSITY OF OXFORD   (United Kingdom)

^am GEORGE MASON UNIVERSITY   (United States)

^an UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^ao JAMES COOK UNIVERSITY   (Australia)

^ap INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^aq Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^ar UNIVERSITY OF CALGARY   (Canada)

^as WAGENINGEN UNIVERSITY   (Netherlands)

^at UNIVERSITY OF GOTHENBURG   (Sweden)

^au UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^av HARVARD UNIVERSITY   (United States)

^aw JACKSON STATE UNIVERSITY   (United States)

^ax NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^ay UNIVERSITY OF ARIZONA   (United States)

^az UNIVERSITY OF HONG KONG   (Hong Kong)

^ba TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^bb UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^bc UNIVERSITY OF OXFORD   (United Kingdom)

^bd UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^be TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^bf Veterans Affairs Eastern Colorado Healthcare System   (United States)

^bg UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^bh UNIVERSITY OF MELBOURNE   (Australia)

^bi ROYAL CHILDREN'S HOSPITAL   (Australia)

^bj The Australian National University   (Australia)

^bk International Foundation for Dermatology   (United Kingdom)

^bl CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^bm PHILIPPS UNIVERSITY MARBURG   (Germany)

^bn CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^bo HEALTH CANADA   (Canada)

^bp MEKELLE UNIVERSITY   (Ethiopia)

^bq KAROLINSKA INSTITUTE   (Sweden)

^br NORTHUMBRIA UNIVERSITY   (United Kingdom)

^bs UNIVERSITY OF EDINBURGH   (United Kingdom)

^bt UNIVERSITY OF SYDNEY   (Australia)

^bu UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^bv TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^bw NATIONAL RESEARCH UNIVERSITY HIGHER SCHOOL OF ECONOMICS   (Russian Federation)

^bx QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^by ADDIS ABABA UNIVERSITY   (Ethiopia)

^bz NORTHWESTERN UNIVERSITY   (United States)

^ca Philipps University Marburg ^*  (Canada)

^cb WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^cc NORTHEASTERN UNIVERSITY   (United States)

^cd MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^ce ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^cf UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^cg UNIVERSITY OF TOKYO   (Japan)

^ch PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^ci UNIVERSITY OF GRONINGEN   (Netherlands)

^cj UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^ck INSTITUTO NACIONAL DE SALUD   (Colombia)

^cl NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^cm UNIVERSITY OF BOLOGNA   (Italy)

^cn Kyung Hee University   (South Korea)

^co BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^cp STAVANGER UNIVERSITY HOSPITAL   (Norway)

^cq UNIVERSITY OF BERGEN   (Norway)

^cr UNIVERSITY OF QUEENSLAND   (Australia)

^cs National Center for Disease Control and Public Health   (Georgia)

^ct UNIVERSITY OF SHEFFIELD   (United Kingdom)

^cu UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^cv UNIVERSITY COLLEGE LONDON   (United Kingdom)

^cw GENENTECH INC   (United States)

^cx National Capital Region   (India)

^cy UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^cz NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^da INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; CHILD; DISABILITY; FEMALE; HEALTH; HUMAN; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PRESCHOOL CHILD; PREVALENCE; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84994730525     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/JAMAONCOL.2015.2892     Document Type: Erratum

References (67)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-171.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2095-2128.
3. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269-1276.
4. Allemani C, Weir HK, Carreira H, et al; CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010.
5. Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290-1314.
6. Coleman MP, Gatta G, Verdecchia A, et al; EUROCARE Working Group. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14(suppl 5):v128-v149.
7. Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063- 2066.
8. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-2260.
9. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2197-2223.
10. Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380(9859):2144-2162.
11. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2129-2143.
12. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2163-2196.
13. Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2071-2094.
14. Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):957- 979. doi:10.1016/S0140-6736(14)60497-9.
15. Doll R, Payne P, Waterhouse J, eds. Cancer Incidence in Five Continents. Vol I. Geneva, Switzerland: Union Internationale Contre le Cancer; 1966.
16. Doll R, Muir C, Waterhouse J, eds. Cancer Incidence in Five Continents. Vol II. Geneva, Switzerland: Union Internationale Contre le Cancer; 1970.
17. Waterhouse J, Muir C, Correa P, Powell J, eds. Cancer Incidence in Five Continents. Vol III. Lyon, France: IARC; 1976.
18. Waterhouse J, Muir C, Shanmugaratnam K, Powell J, eds. Cancer Incidence in Five Continents. Vol IV. Lyon, France: IARC; 1982.
19. Muir C, Mack T, Powell J, Whelan S, eds. Cancer Incidence in Five Continents. Vol V. Lyon, France: IARC; 1987.
20. Parkin D, Raymond L, Young J, et al, eds. Cancer Incidence in Five Continents. Vol VI. Lyon, France: IARC; 1992.
21. Parkin D, Whelan S, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Vol VII. Lyon, France: IARC; 1997.
22. Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D, eds. Cancer Incidence in Five Continents. Vol VIII. Lyon, France: IARC; 2002.
23. Curado MP, Edwards B, Shin HR, et al, eds. Cancer Incidence in Five Continents. Vol IX. Lyon, France: IARC; 2007.
24. Forman D, Bray F, Brewster DH, et al, eds. Cancer Incidence in Five Continents. Vol X. Lyon, France: IARC; 2013.
25. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10:1.
26. GBD 2013 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and YLDs for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. In press.
27. Cho E, Curhan G, Hankinson SE, et al. Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med. 2011;171(16):1487-1493.
28. Chow WH, Gridley G, Fraumeni JF Jr, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343(18):1305-1311.
29. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114(1):101-108.
30. Mandel JS, McLaughlin JK, Schlehofer B, et al. International renal-cell cancer study, IV: occupation. Int J Cancer. 1995;61(5):601-605.
31. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic" - screening and overdiagnosis. N Engl J Med. 2014;371(19):1765-1767.
32. Ho AS, Davies L, Nixon IJ, et al. Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates. Cancer. 2015. doi:10.1002/cncr.29289.
33. Pandeya N, McLeod DS, Balasubramaniam K, et al. Increasing thyroid cancer incidence in Queensland, Australia 1982- 2008: true increase or overdiagnosis? Clin Endocrinol (Oxf). 2015. doi:10.1111/cen.12724.
34. United Nations. United Nations Millennium Development Goals. http://www.un.org/millenniumgoals/.Accessed February 2, 2015.
35. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347-1360.
36. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945): 766 -781. doi:10.1016/S0140-6736(14)60460-8.
37. Di Cesare M, Khang YH, Asaria P, et al; Lancet NCD Action Group. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381(9866):585-597.
38. Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014;311(2):183-192.
39. Pampel F. Tobacco use in sub-Saharan Africa: estimates from the demographic health surveys. Soc Sci Med. 2008;66 (8):1772-1783.
40. Seow A, Poh WT, Teh M, et al. Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev. 2000;9(11):1215-1221.
41. Subbaraman N. Public health: a burning issue. Nature. 2014;513(7517):S16-S17.
42. Wang X-R, Chiu Y-L, Qiu H, Au JSK, Yu IT-S. The roles of smoking and cooking emissions in lung cancer risk among Chinese women in Hong Kong. Ann Oncol. 2009;20(4):746-751.
43. Yin Z, Cui Z, Ren Y, et al. Genetic polymorphisms of TERT and CLPTM1L, cooking oil fume exposure, and risk of lung cancer: a case-control study in a Chinese non-smoking female population. Med Oncol. 2014;31(8):114.
44. Yu ITS, Chiu Y-L, Au JSK, Wong T-W, Tang J-L. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Res. 2006;66(9):4961-4967.
45. Campos NG, Kim JJ, Castle PE, et al. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer. 2012;130(11):2672-2684.
46. Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. Vaccine. 2013;31(suppl 5):F47-F52.
47. Sankaranarayanan R, Nene BM, Dinshaw KA, et al; Osmanabad District Cervical Screening Study Group. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005;116(4):617-623.
48. Sankaranarayanan R, Rajkumar R, Theresa R, et al. Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer. 2004;109(3):461-467.
49. Sauvaget C, Fayette J-M, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011;113(1):14-24.
50. World Health Organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva, Switzerland: World Health Organization; 2014.
51. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology. 1991;13(3):398-406.
52. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127(5):1372-1380.
53. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 1981;2(8256):1129-1133.
54. Yuen M-F, Tanaka Y, Fong DY, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50(1):80-88.
55. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328(25):1797-1801.
56. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-538.
57. Griffiths UK, Hutton G, Das Dores Pascoal E. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique. Health Policy Plan. 2005;20(1):50-59.
58. Tu H-AT, Woerdenbag HJ, Kane S, Riewpaiboon A, van Hulst M, Postma MJ. Economic evaluations of hepatitis B vaccination for developing countries. Expert Rev Vaccines. 2009;8(7):907-920.
59. Lambe M, Eloranta S, Wigertz A, Blomqvist P. Pancreatic cancer: reporting and long-term survival in Sweden. Acta Oncol. 2011;50(8):1220-1227.
60. Kilander C, Mattsson F, Ljung R, Lagergren J, Sadr-Azodi O. Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncol. 2014;53(6):822-829.
61. Khanna A, Mansuri S, Mortimore S, De M, Elliott R, Sharp J. Underreporting of mortality from head and neck carcinoma: our experience at a tertiary head and neck cancer unit. Clin Otolaryngol. 2013;38(1):103-104.
62. Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev. 2012;21(3):474-481.
63. International Agency for Research on Cancer. Global Initiative for Cancer Registry Development (GICR). http://gicr.iarc.fr/. Accessed April 18, 2015.
64. Suwanrungruang K, Sriplung H, Temiyasathit S, et al. Appropriateness of the standard mortality/incidence ratio in evaluation of completeness of population-based cancer registry data. Asian Pac J Cancer Prev. 2011;12(12):3283-3288.
65. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods, II: completeness. Eur J Cancer. 2009;45(5):756-764.
66. Ellis L, Woods LM, Estève J, Eloranta S, Coleman MP, Rachet B. Cancer incidence, survival and mortality: explaining the concepts. Int J Cancer. 2014;135(8):1774-1782.
67. NCD. NCD Global Monitoring Framework. http://www.who.int/nmh/global-monitoring-framework/en/. Accessed February 4, 2015.